venture
Orbis Kicks Off 2025 with €90M Series A Funding in Fierce Biotech Fundraising Tracker
Fierce Biotech Fundraising Tracker 2025, Orbis Series A Funding, Biotech Venture Capital, 2025 Biotech Investments, Series A Funding Rounds
2024 Biotech IPOs: Insights and Trends
Biotech IPOs, 2024 IPO trends, biopharma sector, initial public offerings, venture capital investment, healthcare innovation.
Biotech Funding Boom: Tasca and Citryll Secure Significant Investments
Biotech fundraising, venture capital, Tasca, Citryll, Fierce Biotech Fundraising Tracker ’24
Dimension Secures $500M for Second Fund, Focusing on the Intersection of Science and Technology
Dimension, Venture Capital, Science, Technology, Biotech, AI, Machine Learning, Life Sciences, Innovation
Forbion Secures Over €2 Billion in Largest Fundraising to Date, Supporting 30 Biotechs
Forbion, venture capital, life sciences, fundraising, biotechs, Forbion Growth Opportunities Fund III, Forbion Ventures Fund VII
Kurma Partners Secures €140M for Biofund IV, Aiming for €250M to Fuel European Healthcare Innovation
Kurma Partners, Biofund IV, Healthcare Innovation, Venture Capital, European Biotech, Healthcare Investment
Bain Capital Raises $3 Billion for Fourth Life Sciences Fund to Support Innovative Biotech Startups
Bain Capital, Life Sciences Fund, Biotech Startups, Venture Capital, Funding
Biotech IPO Market Sees Shifts in Funding and Investor Appetite
biotech IPOs, crossover funding, venture capital, clinical-stage assets, market correction, investor demand
venBio Secures $528M for Fifth Life Sciences Venture Capital Fund
venBio, life sciences, venture capital, Fund V, biotech investment
venBio Secures $528M for Fifth Life Sciences Venture Capital Fund
venBio, life sciences, venture capital, fund closing, biotech startups, biopharmaceuticals